Read the latest news from Northwestern University Feinberg School of Medicine’s Center for Translational Metabolism and Health. The links below take you to articles where you can learn more about our members' latest achievements, awards and honors.
- From Student to Scientist: Exploring Endomucin Research in the Thompson Lab - A Summer of Hands-On Research10.21.2023
Sophia Serrano, a Mexican/Puerto Rican American scholar from Chicago's West side, dedicated her summer to diligent work at the Thompson Lab within Northwestern University's Feinberg School of Medicine. As a returning SciHigh Scholar at Northwestern University's GoKIDNEY Center, she passionately delved into medical science. Sophia's determination and inquisitiveness guided her in exploring endomucin research, revealing how curiosity and dedication can unveil new horizons in STEM.
- Northwestern University Awarded Nearly $5 Million NIH Grant to Revolutionize Kidney Research09.21.2023Northwestern has successfully secured a substantial grant of nearly $ 5 million from the National Institutes of Health (NIH) to establish a cutting-edge center dedicated to kidney research. This funding will enable the department to create a center that will leverage innovations from the physical sciences to tackle pressing challenges in kidney research.
Northwestern University investigators have developed the first electronic device for continuously monitoring the health of transplanted organs in real time.
- Tamara Isakova, MD Appointed as Interim Chief of Nephrology and Hypertension09.01.2023Join us in congratulating Dr. Tamara Isakova, MD, who has been appointed Interim Chief of Nephrology and Hypertension in the Department of Medicine. Her leadership extends beyond Northwestern, as she chairs the Theme Chair for the 2024 World Congress of Nephrology Program Committee and serves on various steering committees. With editorial roles in top nephrology journals, Dr. Isakova continues to make significant contributions to the medical community.Join us in welcoming Dr. Isakova to her new position!
At the September meetings of the American Heart Association (AHA) Hypertension Council, Dr. Daniel Batlle will deliver the 2023 Donald Seldin Lecture, an esteemed award presented by the Kidney and Cardiovascular Councils.
Aerobic glycolysis, the process by which cells transform glucose into lactate, is essential for eye development in mammals, according to a new Northwestern Medicine study published in Nature Communications.
Douglas E. Vaughan, MD, has announced his intention to step down as chair of The Department of Medicine, effective September 1; Susan Quaggin, MD, has been named as his successor.
Northwestern Medicine investigators have discovered that the overexpression of a specific transcription factor prevented bone loss in mouse models with complications from chronic kidney disease, according to a recent study published in the Journal of Clinical Investigation.
Northwestern Medicine scientists have uncovered how peptides produced by bones during inflammation prevent anemia in mice, according to a recent study published in the journal Blood.
Susan Quaggin, MD, Director of NUGoKidney and FCVRRI was one of eight Northwestern University Faculty members recently elected to the American Academy of Arts & Science, one of the nation’s oldest and most prestigious honorary societies.
Join us in congratulation her and the nearly 270 members elected in 2023 from academia, the arts, industry, policy, research, and science.
Four Feinberg faculty have been elected members of the American Academy of Arts and Sciences, one of the nation’s oldest and most prestigious honorary societies.
- Take the Challenge04.17.2023
850 million people worldwide have kidney disease, but few know its dangers. Take the #850Challenge and raise awareness by walking 8.5K steps, cycling 85 miles, or completing 8.5 minutes of high-intensity training. Share your progress w/ us on Twitter and Instagram by using the hashtag (#850Challenge) and tagging us @NU_Nephrology.
- 02.15.2023As we reflect on the year and plan for the new year, NUGoKidney would like to express gratitude for your continued support and dedication to kidney health. We can't wait for you to see what we have in store for this year!To celebrate another incredible year, we are excited to share some of the exciting moments and achievements from this past year!
- 02.02.2023Targeting VEGFR-3 in kidney lymphatics has been proposed as a method to treat kidney disease. However, expression of VEGFR-3 is not lymphatic-specific. Assistant Professor of Medicine (Nephrology and Hypertension) at Northwestern, Michael D Donnan, MD and team provide valuable information for therapeutic development targeting these pathways in recent AJP Renal publication.
- 02.02.2023While nephrology has reached many milestones in the past few decades,Susan Quaggin, MD, FASN, NUGoKidney Director and former POTASN, encouraged nephrologists to turn this moment into a movement. With 8 breakthroughs and 9 FDA approval in 2022, now is better time than any to join the revolution to end kidney disease by challenging lawmakers, policymakers and policies that threaten patients and the care nephrologists provide.
- 02.01.2023John Rogers, SM, PhD, executive director of Northwestern University's Querrey Simpson Institute for Bioelectronics, and Lorenzo Gallon, MD, medical director of the Translational Medicine program are working to treat kidney patients as early as possible and avoid the need for a biopsy by developing wearable technology to detect the earliest signs of kidney transplant rejection.Together they have developed an implantable, wireless sensor that attaches to the kidney and measures blood flow and temperature and through testing, have found that temperature—but not blood flow—provides an early warning about rejection.
- 01.31.2023NUGoKidney Director and former POTASN, Susan Quaggin, MD, FASN interviewed with thirty television and radio stations to help raise awareness of the thirty-seven million American's living with kidney disease. Focusing on kidney health, early intervention and prevention, Dr. Quaggin encourages everyone to get informed and emphasizes the importance of knowing whether you are at risk.
Susan Quaggin, MD, has been presented one of The American Heart Association’s 2022 Distinguished Scientist awards, which honor members who have significantly advanced the understanding of cardiovascular, stroke or brain health.
The membrane-bound form of the ACE2 protein is the essential receptor for enabling COVID-19 infectivity, according to a Northwestern Medicine study.
Dozens of faculty members and fourth-year medical students were recognized for their scholarly and clinical excellence at Feinberg’s Honors Day, held May 20.
Expression of a growth factor after heart injury activates the lymphatic system, spurring leukocytes to help clear away dying cells, according to a recent study.
Northwestern Medicine continues to help advance the understanding of the COVID-19 pandemic and its widespread impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research to highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.
Feinberg students are being trained in a two-week emergency preparedness course on how to manage natural disasters, mass shootings or pandemics.
A well-established cancer cell transcription factor and its newly identified co-factor work together to drive cancer cell proliferation, according to a Northwestern Medicine study published in Science Advances.
A new study has identified naturally occurring nano-sized particles that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies.
Feinberg experienced a year of exceptional growth, perseverance, and collaboration in 2021, from honors and awards to unprecedented research discoveries.
On a late September evening of 2021, the world lost one of the last giants of Medicine. Dr Lewis Landsberg passed in Cape Cod, where he loved to spend part of the summers with his beloved wife Jill and visiting family and friends.